DionyMed Holdings Inc. Completes $33.8 Million Private Placement of Subscription Receipts and Going-Public Transaction

November 28, 2018

DionyMed Holdings Inc. completed a private placement offering of subscription receipts for aggregate gross proceeds of approximately $33.8 million on November 1, 2018. The offering was completed in connection with DionyMed Holdings Inc.’s proposed business combination with Sixonine Ventures Corp., which subsequently closed on November 28, 2018 (the “Business Combination”). In connection with the Business Combination, DionyMed Holdings Inc. changed its name to “DionyMed Brands Inc.” and listed on Canadian Securities Exchange (CSE: DYME).

DionyMed Brands Inc. is a multi-state cannabis brands and distribution platform, supporting cultivators, manufacturers and brands in the medical and adult-use cannabis markets in the United States. Upon completion of the Business Combination, the subscription receipts were automatically converted into one common share and one warrant of DionyMed Holdings Inc., which were then immediately exchanged for subordinate voting shares and subordinate voting share purchase warrants of DionyMed Brands Inc.

Canaccord Genuity Corp. acted as lead agent in respect of the offering together with a syndicate of agents that included Cormark Securities Inc. and Beacon Securities Limited.

Wildeboer Dellelce LLP acted for the agents in connection with the offering with a team comprised of Perry Dellelce, Sanjeev Patel, Patricia Good and Jessica Coco (corporate/securities).